Press Coverage

Benefits of Cellvizio in Chronic Digestive Disease

28 April 2017

Robert Danbert, gastroenterologist at San Angelo Community Medical Center, was recognized Thursday as the top U.S. user in 2016 of Cellvizio, an endomicroscopy system that provides physicians with minimally invasive, microscopic images of tissue by generating optical biopsies. Danbert uses Cellvizio as a diagnostic tool for the majority of his gastroenterology cases, most often to monitor patients with gastroesophageal reflux disease (GERD) to determine changes in their esophageal lining, benefiting more than 300 patients in the local area in 2016, according to a news release by The Ruth Group, a health care communications company. GERD is a chronic digestive disease that occurs when stomach acid or, occasionally, stomach content, flows back into the esophagus, irritating the esophagus lining. Both acid reflux and heartburn are common digestive conditions associated with the disease.

Latest News

Mauna Kea Technologies Updates Its Financial Calendar 

Mauna Kea Technologies Updates Its Financial Calendar 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Announces Major Milestone for Cellvizio® in Pancreatic Cysts with CLIMB Study Selected for ASGE Presidential Plenary Session at DDW 2026 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

Mauna Kea Technologies Accelerates International Expansion with New Regulatory Clearances in Switzerland and the United Kingdom 

No results found.